drugset / Trial / NCT00771719

Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia

NCT00771719

Phase 1 Terminated 1 enrolled Basilea Pharmaceutica
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to measure the levels of ceftobiprole in the blood, urine and tissues of the lungs during and after administration of four doses of ceftobiprole. Safety of the drug will also be evaluated.

Timeline

Start
2008-10
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftobiprole Small molecule 1 g Intravenous

Indications

No indication recorded.